XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 16,983 $ 8,253 $ 45,450 $ 20,187
General and administrative 4,929 2,316 12,591 6,032
Total operating expenses 21,912 10,569 58,041 26,219
Loss from operations (21,912) (10,569) (58,041) (26,219)
Interest income 406 711 1,747 1,618
Net loss (21,506) (9,858) (56,294) (24,601)
Other comprehensive income / (loss):        
Unrealized gain / (loss) on available for sales securities (198) 16 453 145
Total comprehensive loss $ (21,704) $ (9,842) $ (55,841) $ (24,456)
Net loss per share - basic and diluted $ (0.73) $ (0.37) $ (1.94) $ (1.59)
Weighted average shares of common stock outstanding - basic and diluted 29,488,739 26,841,149 29,066,006 15,489,216